Eisai to Launch First Chocola BB Brand Product "Chocola BB Royal Drink" in China
October 21, 2014     Japanese 
  JCN 
	  Network - Home
JCN Newswire
  Home  |  Companies  | Annual Reports  |  CSR  | News Alerts     
 
Eisai to Launch First Chocola BB Brand Product
Share:
Eisai to Launch First Chocola BB Brand Product "Chocola BB Royal Drink" in China

Tokyo, July 2, 2014 - (JCN Newswire) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that it has launched its Chocola BB Royal Drink in China. This marks the first Chocola BB series product launched in China by Eisai.

In addition to including the ingredients that have long been the foundation of the Chocola BB brand in Japan, such as vitamin B6, nicotinamide, royal jelly and taurine to support consumers' beauty and wellness, Chocola BB Royal Drink also specially contains collagen, L-carnitine, coix seed, polygonatum rhizome and goji berry to specifically address the needs of consumers in China. It also features an easy-to-drink pineapple flavor and is low in calories with approximately 9 kcal per bottle.

In recent years, the healthcare needs of consumers in China have been increasing in line with economic growth. Furthermore, beauty and healthcare related items have been very popular among women in China. In response to these trends, Eisai has launched Chocola BB Royal Drink as the first of its Chocola BB series of products in order to support consumers' beauty and wellness.

Chocola BB Royal Drink is sold through the internet in order to make the product readily accessible to women throughout the country. Following this new product launch to establish a foothold in China, Eisai plans to further introduce its over-the-counter (OTC) products into other countries in Asia.

Since its first product introduction in 1952, the Chocola BB series of products have been widely used by many customers in Japan, Taiwan and Hong Kong as a reliable healthcare brand. In Japan, Eisai has developed a wide range of products including mainstays such as Chocola BB Plus tablets (third-class OTC drug), Chocola BB Royal 2 (designated quasi-drug, drink), Chocola BB Sparkling (food with nutrient function claims, drink) and Bi Chocola (food with nutrient function claims) in response to the diverse needs of consumers.

By marketing the Chocola BB series of products, Eisai is committed to supporting the beauty and wellness of a wider group of consumers in the Asia region, including Japan and China.

About Eisai

Eisai Co., Ltd. (TSE: 4523; ADR: ESALY) is a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Eisai focuses its efforts in three therapeutic areas: integrative neuroscience, including neurology and psychiatric medicines; integrative oncology, which encompasses oncotherapy and supportive-care treatments; and vascular/immunological reaction. Through a global network of research facilities, manufacturing sites and marketing subsidiaries, Eisai actively participates in all aspects of the worldwide healthcare system. For more information about Eisai Co., Ltd., please visit www.eisai.com.

Contact:

Public Relations Department,
Eisai Co., Ltd.
+81-3-3817-5120

 


July 2, 2014
Source: Eisai

Eisai (TSE: 4523) (U.S: ESALY)

From the Japan Corporate News Network
http://www.japancorp.net
Topic: New Product
View more news from these Sectors: Biotech, Drugs & OTC, Food & Beverage


 
CSR Report Download
Annual Reports

  More >>    
Most Popular


About JCN | Privacy Policy | Terms of Use | JCN Network (日本語)